BV
Bharat Vasudevan
About Bharat Vasudevan
Data last updated:
Bharat Vasudevan is a Director at Chemo India Formulation Private Limited (since 2019), Director at Senador Laboratories Private Limited (since 2024) and Director at Airpharm India Private Limited (since 2024). The companies operate in Pharma and Food And Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹136 Cr; the largest is Chemo India Formulation Private Limited at ₹107 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Chemo India Formulation Private Limited U85100TG2015FTC100239 | Director | 06 Jun 2019 | 2015 | ₹107 Cr (FY 2025) | Active |
| Senador Laboratories Private Limited U21001TS2023PTC171514 | Director | 12 Mar 2024 | 2023 | ₹29.13 Cr (FY 2024) | Active |
| Airpharm India Private Limited U52292TS2024FTC191307 | Director | 25 Nov 2024 | 2024 | Active |
Board colleagues of Bharat Vasudevan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manuel Ignacio Barro | 05134464 | Chemo India Formulation Private Limited | Director |
| Maria Sandra Martin Moran | 07128205 | Chemo India Formulation Private Limited | Director |
| Ramachandra Kumar Kurumaddali | 02066941 | Chemo India Formulation Private Limited , Senador Laboratories Private Limited and 1 more | Managing Director |
| Satheesh Rao Ponugoti | Chemo India Formulation Private Limited | Company Secretary | |
| Carlos Romero Camacho Silos | 10462233 | Senador Laboratories Private Limited , Airpharm India Private Limited | Director |
| Rafael De Andrade | 10462247 | Senador Laboratories Private Limited | Additional Director |
| Rafael Gallego Ollero | 10848748 | Airpharm India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bharat Vasudevan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharat Vasudevan
Bharat Vasudevan currently holds 3 directorships: Chemo India Formulation Private Limited (Director, since 06 Jun 2019, revenue ₹107 Cr (FY 2025)); Senador Laboratories Private Limited (Director, since 12 Mar 2024, revenue ₹29.13 Cr (FY 2024)); Airpharm India Private Limited (Director, since 25 Nov 2024).
Bharat Vasudevan was first appointed on 06 Jun 2019 as Director at Chemo India Formulation Private Limited. The most recent appointment on record is 25 Nov 2024 at Airpharm India Private Limited.
The 2 current companies of Bharat Vasudevan that report revenue have a combined latest revenue of ₹136 Cr: Chemo India Formulation Private Limited ₹107 Cr (FY 2025); Senador Laboratories Private Limited ₹29.13 Cr (FY 2024).
The current boards of Bharat Vasudevan's companies include Manuel Ignacio Barro (Chemo India Formulation Private Limited), Maria Sandra Martin Moran (Chemo India Formulation Private Limited), Ramachandra Kumar Kurumaddali (Chemo India Formulation Private Limited), Satheesh Rao Ponugoti (Chemo India Formulation Private Limited), Carlos Romero Camacho Silos (Senador Laboratories Private Limited), Rafael De Andrade (Senador Laboratories Private Limited), among others.